Sommario

• • ·Where are the long COVID trials?

    Pagina :879

     
• • ·Bivalent omicron (BA.1) booster vaccination against SARS-CoV-2

    Pagina :880-881

    Andrey V Vasin, Marina A Stukova

     
• • ·Effectiveness of bivalent mRNA booster vaccines against COVID-19: methodological and public health considerations

    Pagina :881-882

    Anna Stoliaroff-Pepin, Thomas Harder

     
• • ·The performance of rapid antigen tests against SARS-CoV-2 variants

    Pagina :883-884

    Jacqueline Prestedge, Deborah A Williamson

     
• • ·1 + 1 dose schedule for pneumococcal child vaccination: new normal?

    Pagina :884-885

    Hans-Christian Slotved, Kurt Fuursted

     
• • ·Molecular testing in suspected infectious diarrhoea—the value of negative results

    Pagina :886-887

    Mark H Wilcox

     
• • ·A novel Rift Valley fever vaccine

    Pagina :887-889

    Saskia Bronder, Martina Sester

     
• • ·Fractional dose yellow fever vaccination, coming of age

    Pagina :889-890

    Anna H E Roukens, Leo G Visser

     
• • ·Leveraging the positives from the pandemic to strengthen infectious disease care in low-income and middle-income countries

    Pagina :890-892

    Boghuma K Titanji, Madhukar Pai

     
• • ·Tuberculosis recovery in Georgia: implementing more by 24

    Pagina :893-894

    Nana Kiria, Nino Lomtadze, Nelly Solomonia, Rusudan Aspindzelashvili, Maka Danelia, Irakli Gabisonia, Marina Janjgava, Irma Khonelidze, Maia Kipiani, Nestani Tukvadze, Henry M Blumberg, Russell R Kempker, Jennifer Furin, Zaza Avaliani

    
• • ·Bivalent COVID-19 mRNA vaccine against omicron subvariants in immunocompromised patients

    Pagina :e266

    Javier T Solera, Matthew Ierullo, Berta G Arbol, Faranak Mavandadnejad, Alexandra Kurtesi, Freda Qi, Queenie Hu, Anne-Claude Gingras, Victor H Ferreira, Atul Humar, Deepali Kumar

      
• • ·Selection of Neisseria gonorrhoeae ceftriaxone resistance using doxycycline post-exposure prophylaxis

    Pagina :e268

    David M Whiley, Jacob A Tickner, Ratan L Kundu, Tiffany R Hogan, Sebastiaan J van Hal, Monica M Lahra

     
• • ·Multidrug-resistant infections in war victims in Ukraine

    Pagina :e270

    Scott J C Pallett, Alex Trompeter, Marina Basarab, Luke S P Moore, Sara E Boyd

    
• • ·Mucosal IgA protects against BQ.1 and BQ.1.1 infection

    Pagina :e272

    Ulrika Marking, Oscar Bladh, Sebastian Havervall, Nina Greilert-Norin, Max Gordon, Jessica J Alm, Kim Blom, Mikael Åberg, Jonas Klingström, Charlotte Thålin

      
• • ·Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex

    Pagina :e274

    Simone Giuliano, Francesco Sbrana, Carlo Tascini

    
• • ·Sulbactam–durlobactam for infections caused by Acinetobacter baumannii–calcoaceticus complex – Authors’ reply

    Pagina :e275

    Keith S Kaye, Sarah M McLeod, John P O’Donnell, David Altarac

    
• • ·Heteroresistance to cefepime–taniborbactam in metallo-β-lactamase-encoding Enterobacterales

    Pagina :e277

    Carter Abbott, Sarah W Satola, David S Weiss

     
• • ·Correction to Lancet Infect Dis 2023; 23: e259–65

    Pagina :e279

    
• • ·Correction to Lancet Infect Dis 2023; published online https://doi.org/10.1016/S1473-3099(22)00877-5

    Pagina :e279

    
• • ·A new toolkit for WASH programmes

    Pagina :e280

    Timothy Jesudason

     
• • ·A new research agenda to combat antimicrobial resistance

    Pagina :e281

    Timothy Jesudason

     
• • ·Iraq tackles meningitis outbreak

    Pagina :e282

    Sanjeet Bagcchi

     
• • ·Sulbactam–durlobactam for Acinetobacter pneumonia

    Pagina :e283

    Ammara Mushtaq, Abhinandan Anand Raman

     
• • ·Increasing Marburg VHF outbreaks in Africa

    Pagina :e284

    Esther Nakkazi

     
• • ·Infectious disease surveillance update

    Pagina :e286

    Ruth Zwizwai

    Mappa Mappa
• • ·Research in brief

    Pagina :e287

    Sharmila Devi

    Mappa Mappa
• • ·Margaret Keller

    Pagina :895

    Sanjeet Bagcchi

     
• • ·Marta Boffito—The happy warrior

    Pagina :896

    Farooq Kazi, Ammara Mushtaq

     
• • ·Marc Shamier—young doctor with a global vision

    Pagina :897

    Tony Kirby

     
• • ·Steen Ethelberg—investigating infectious disease outbreaks

    Pagina :898

    Udani Samarasekera

     
• • ·Sharing the road during the COVID-19 pandemic

    Pagina :899

    Henrietta Dunsmuir

     
• • ·A tale of two pandemics

    Pagina :900

    Sylvia Warren

     
• • ·Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

    Pagina :901-913

    Ngoc H Tan, Daryl Geers, Roos S G Sablerolles, Wim J R Rietdijk, Abraham Goorhuis, Douwe F Postma, Leo G Visser, Susanne Bogers, Laura L A van Dijk, Lennert Gommers, Leanne P M van Leeuwen, Annemarie Boerma, Sander H Nijhof, Karel A van Dort, Marion P G Koopmans, Virgil A S H Dalm, Melvin Lafeber, Neeltje A Kootstra, Anke L W Huckriede, Debbie van Baarle, Luca M Zaeck, Corine H GeurtsvanKessel, Rory D de Vries, P Hugo M van der Kuy, SWITCH ON Research Group

    Riassunto Riassunto Mappa Mappa   
• • ·Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study

    Pagina :914-921

    Ronen Arbel, Alon Peretz, Ruslan Sergienko, Michael Friger, Tanya Beckenstein, Hadar Duskin-Bitan, Shlomit Yaron, Ariel Hammerman, Natalya Bilenko, Doron Netzer

    Riassunto Riassunto Mappa Mappa  
• • ·Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study

    Pagina :922-932

    David W Eyre, Matthias Futschik, Sarah Tunkel, Jia Wei, Joanna Cole-Hamilton, Rida Saquib, Nick Germanacos, Andrew R Dodgson, Paul E Klapper, Malur Sudhanva, Chris Kenny, Peter Marks, Edward Blandford, Susan Hopkins, Tim E A Peto, Tom Fowler

    Riassunto Riassunto Mappa Mappa   
• • ·Efficacy against pneumococcal carriage and the immunogenicity of reduced-dose (0 + 1 and 1 + 1) PCV10 and PCV13 schedules in Ho Chi Minh City, Viet Nam: a parallel, single-blind, randomised controlled trial

    Pagina :933-944

    Beth Temple, Hau Phuc Tran, Vo Thi Trang Dai, Heidi Smith-Vaughan, The VPT-II Collaborator Group, Paul Vincent Licciardi, Catherine Satzke, Thuong Vu Nguyen, Kim Mulholland, Anne Balloch, Jemima Beissbarth, Kathryn Bright, Rachel Ann Higgins, Jason Hinds, Pham Thi Hoan, Monica Larissa Nation, Cattram Duong Nguyen, Belinda Daniela Ortika, Thanh V Phan, Tran Linh Phuong, Leena Spry, Ho Nguyen Loc Thuy, Nguyen Trong Toan, Doan Y Uyen, Le Thi Tuong Vy

    Riassunto Riassunto Mappa Mappa   
• • ·Clinical impact of syndromic molecular point-of-care testing for gastrointestinal pathogens in adults hospitalised with suspected gastroenteritis (GastroPOC): a pragmatic, open-label, randomised controlled trial

    Pagina :945-955

    Nathan J Brendish, Kate R Beard, Ahalya K Malachira, Alex R Tanner, Langizya Sanga-Nyirongo, Markus Gwiggner, J R Fraser Cummings, Helen E Moyses, Tristan W Clark

    Riassunto Riassunto Mappa Mappa   
• • ·Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trial

    Pagina :956-964

    Daniel Jenkin, Daniel Wright, Pedro M Folegatti, Abigail Platt, Ian Poulton, Alison Lawrie, Nguyen Tran, Amy Boyd, Cheryl Turner, John N Gitonga, Henry K Karanja, Daisy Mugo, Katie J Ewer, Thomas A Bowden, Sarah C Gilbert, Bryan Charleston, Pontiano Kaleebu, Adrian V S Hill, George M Warimwe

    Riassunto Riassunto Mappa Mappa   
• • ·Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Pagina :965-973

    Aitana Juan-Giner, Maria L Namulwana, Derick Kimathi, Kyra H Grantz, Gamou Fall, Moussa Dia, Ndeye S Bob, Amadou Alpha Sall, Caroline Nerima, Mateus Kambale Sahani, Edgar M Mulogo, Immaculate Ampeire, Joachim Hombach, Deborah Nanjebe, Juliet Mwanga-Amumpaire, Derek A T Cummings, Philip Bejon, George M Warimwe, Rebecca F Grais

    Riassunto Riassunto Mappa Mappa   
• • ·Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Pagina :974-982

    Derick Kimathi, Aitana Juan-Giner, Benedict Orindi, Kyra H Grantz, Ndeye S Bob, Stanley Cheruiyot, Mainga Hamaluba, Naomi Kamau, Gamou Fall, Moussa Dia, Moses Mosobo, Felix Moki, Kenneth Kiogora, Oscar Chirro, Alexander Thiong’o, Jane Mwendwa, Andrew Guantai, Henry K Karanja, John Gitonga, Daisy Mugo, Kelly Ramko, Ousmane Faye, Eduard J Sanders, Rebecca F Grais, Philip Bejon, George M Warimwe

    Riassunto Riassunto Mappa Mappa   
• • ·Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa

    Pagina :e288

    Bavesh D Kana, Patrick Arbuthnot, Benjamin K Botwe, Yahya E Choonara, Fatima Hassan, Hechmi Louzir, Precious Matsoso, Penny L Moore, Apollo Muhairwe, Kubendran Naidoo, Margareth Ndomondo-Sigonda, Shabir A Madhi

    Riassunto Riassunto Mappa Mappa  
• • ·How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?

    Pagina :e301

    Kamini Walia, Marc Mendelson, Gagandeep Kang, Ramasubramanian Venkatasubramanian, Rina Sinha, Sonam Vijay, Balaji Veeraraghavan, Buddha Basnyat, Camilla Rodrigues, Nitin Bansal, Pallab Ray, Purva Mathur, Ram Gopalakrishnan, Vinod C Ohri

    Riassunto Riassunto Mappa Mappa  
• • ·Leveraging lessons from the COVID-19 pandemic to strengthen low-income and middle-income country preparedness for future global health threats

    Pagina :e310

    Ayoade Alakija

    Riassunto Riassunto Mappa Mappa
• • ·RTS,S/AS01 malaria vaccine—proven safe and effective?

    Pagina :e318

    Anders Björkman, Christine Stabell Benn, Peter Aaby, Allan Schapira

    Riassunto Riassunto Mappa Mappa
• • ·The response of mpox-associated inflammatory syndrome to steroid therapy

    Pagina :e323

    Cesar A Arias, William R Miller, Randall Olsen, Jimmy Gollihar, Andrea Armstrong

     
• • ·Yeast phagocytosis by eosinophils: a case of disseminated histoplasmosis diagnosed in a peripheral blood smear

    Pagina :e325

    Javier Camuña Correa, María Paniagua García, Concepción Prats-Martín, María José Gómez-Gómez, Rosario M Morales-Camacho, Jose Antonio Farah Gamarra, María J Buitrago, Eusebio Martín-Chacón